Fay Nicolson
@faynicolson.bsky.social
PI @danafarber.bsky.social | Medical Imaging and Cancer Theranostics
Pinned
Fay Nicolson
@faynicolson.bsky.social
· Dec 17
The 2024 generation
Nature Cancer - Twelve early-career researchers who embarked on their independent research paths in 2024 reflect on their experience from their journey so far, describe the opportunities they...
rdcu.be
Grateful to contribute to@natureportfolio.bsky.social @naturecancer.bsky.social Viewpoint reflecting on my 1st year as an independent investigator@danafarber.bsky.social 🧪Thanks to lab members, mentors, collaborators, friends, & family who have supported me this year! 💫 ✨ 💡 rdcu.be/d3R8r
Reposted by Fay Nicolson
Looking to compare brightness between radionuclides? look no further! Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System. A collection over the years including over 23 radionuclides! @grimmrad.bsky.social and @lewislabmskcc.bsky.social
jnm.snmjournals.org/content/earl...
jnm.snmjournals.org/content/earl...
Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
Cerenkov (or Cherenkov) luminescence occurs when charged particles exceed the phase velocity of a given medium. Cerenkov as a modality has gained interest for visualization of numerous radionuclides. ...
jnm.snmjournals.org
April 4, 2025 at 8:38 PM
Looking to compare brightness between radionuclides? look no further! Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System. A collection over the years including over 23 radionuclides! @grimmrad.bsky.social and @lewislabmskcc.bsky.social
jnm.snmjournals.org/content/earl...
jnm.snmjournals.org/content/earl...
Reposted by Fay Nicolson
These are extremely challenging times for early-career faculty. Here is my office's small contribution to make their hard and important work a bit easier:
Download our curated and comprehensive database of funding opportunities for early-career faculty.
Here: research.jhu.edu/rdt/funding-...
Download our curated and comprehensive database of funding opportunities for early-career faculty.
Here: research.jhu.edu/rdt/funding-...
March 6, 2025 at 8:28 PM
These are extremely challenging times for early-career faculty. Here is my office's small contribution to make their hard and important work a bit easier:
Download our curated and comprehensive database of funding opportunities for early-career faculty.
Here: research.jhu.edu/rdt/funding-...
Download our curated and comprehensive database of funding opportunities for early-career faculty.
Here: research.jhu.edu/rdt/funding-...
Reposted by Fay Nicolson
@danafarber.bsky.social announced the Center for RAS Therapeutics, an initiative to advance treatments for patients with RAS-mutant cancers. Learn more at https://bit.ly/3DIgdqi
DFCI Initiative to Study RAS-Driven Cancers
Dana-Farber Cancer Institute announced the launch of the Center for RAS Therapeutics, an initiative that aims to advance new treatments for patients with RAS-mutant cancers through collaborations between researchers, industry, and other academic medical centers. RAS mutations are found in 20% of all cancers and are a major driver of certain malignancies, such as pancreatic and colorectal cancers.
bit.ly
January 8, 2025 at 7:30 PM
@danafarber.bsky.social announced the Center for RAS Therapeutics, an initiative to advance treatments for patients with RAS-mutant cancers. Learn more at https://bit.ly/3DIgdqi
Reposted by Fay Nicolson
A new post in Science Careers for our open-rank faculty search at the Hunter College Dept of Biological Sciences: jobs.sciencecareers.org/job/668588/o...
December 20, 2024 at 4:20 AM
A new post in Science Careers for our open-rank faculty search at the Hunter College Dept of Biological Sciences: jobs.sciencecareers.org/job/668588/o...
Reposted by Fay Nicolson
SAVE THE DATE: The 4th Transatlantic Exchange in Oncology between @danafarber.bsky.social and Gustave Roussy will take place in Paris on Wednesday March 19, 2025 and will focus on Radiopharmaceuticals.
Free registration and Hybrid option!
In partnership with Servier and Medscape
Free registration and Hybrid option!
In partnership with Servier and Medscape
December 16, 2024 at 1:40 PM
SAVE THE DATE: The 4th Transatlantic Exchange in Oncology between @danafarber.bsky.social and Gustave Roussy will take place in Paris on Wednesday March 19, 2025 and will focus on Radiopharmaceuticals.
Free registration and Hybrid option!
In partnership with Servier and Medscape
Free registration and Hybrid option!
In partnership with Servier and Medscape
Reposted by Fay Nicolson
⭐️As every December don't miss our Year In Review Focus Issue featuring 2024's highlights in #cancerresearch and #oncology.
2024 in Review
Nature Cancer’s 2024 in Review Focus comprises news, analysis and comment articles on the most exciting advances and biggest challenges of the past year, ...
www.nature.com
December 18, 2024 at 4:11 PM
⭐️As every December don't miss our Year In Review Focus Issue featuring 2024's highlights in #cancerresearch and #oncology.
Grateful to contribute to@natureportfolio.bsky.social @naturecancer.bsky.social Viewpoint reflecting on my 1st year as an independent investigator@danafarber.bsky.social 🧪Thanks to lab members, mentors, collaborators, friends, & family who have supported me this year! 💫 ✨ 💡 rdcu.be/d3R8r
The 2024 generation
Nature Cancer - Twelve early-career researchers who embarked on their independent research paths in 2024 reflect on their experience from their journey so far, describe the opportunities they...
rdcu.be
December 17, 2024 at 3:37 PM
Grateful to contribute to@natureportfolio.bsky.social @naturecancer.bsky.social Viewpoint reflecting on my 1st year as an independent investigator@danafarber.bsky.social 🧪Thanks to lab members, mentors, collaborators, friends, & family who have supported me this year! 💫 ✨ 💡 rdcu.be/d3R8r